Author

S. F. Sarabia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Badachhape· 1 shared A. C. Barbosa· 1 shared A. C. V. Krepischi· 1 shared A. M. Ibarra· 1 shared A. Major· 1 shared A. P. Shah· 1 shared A. Roy· 1 shared B. J. Mistretta· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Badachhape

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells

S. E. Woodfield, B. J. Mistretta, R. H. Patel, A. M. Ibarra, K. E. Fisher, S. F. Sarabia, I. Gandhi, J. Reuther, Z. Starosolski, A. Badachhape, A. P. Shah, S. R. Larson, R. K. Srivastava, Y. Shi, R. S. Whitlock, , S. A. Vasudevan

This study develops murine hepatoblastoma models from HepT1 cells that exhibit high-risk features like vascular invasion, metastasis, and circulating tumor cells.

Biology Open · Sep 12, 2022Peer-reviewedCancer Biology

Mutational burden of hepatoblastomas: a role for the CX3CL1/CX3CR1 chemokine signaling pathway

T. Aguiar, M. Prates, S. Costa, T. Rodrigues, J. S. de Barros, A. C. Barbosa, M. Maschietto, R. Valieris, G. R. Fernandes, M. Cypriano, S. R. C. de Toledo, A. Major, I. Tojal, M. L. d. P. Apezzato, D. M. Carraro, , A. C. V. Krepischi

This study identifies CX3CL1/CX3CR1 pathway activation and a novel mutational signature in hepatoblastomas through exome sequencing and expression analysis.

bioRxiv · Feb 22, 2019 · PreprintCancer Biology